Format

Send to

Choose Destination
See comment in PubMed Commons below
Clin Lung Cancer. 2015 Sep;16(5):e101-4. doi: 10.1016/j.cllc.2015.01.009. Epub 2015 Feb 7.

Response to Crizotinib in a Patient With Lung Adenocarcinoma Harboring a MET Splice Site Mutation.

Author information

1
Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, MA.
2
N-of-One Inc, Lexington, MA.
3
Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, MA. Electronic address: dbarbie@partners.org.

KEYWORDS:

Crizotinib; Lung adenocarcinoma; MET; Splice site mutation

PMID:
25769807
PMCID:
PMC4529392
DOI:
10.1016/j.cllc.2015.01.009
[Indexed for MEDLINE]
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science Icon for PubMed Central
    Loading ...
    Support Center